Synovus Financial’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.38M | Buy |
24,961
+3,472
| +16% | +$181K | 0.02% | 452 |
|
|
2025
Q2 | $926K | Buy |
21,489
+3,952
| +23% | +$152K | 0.01% | 519 |
|
|
2025
Q1 | $694K | Buy |
17,537
+3,751
| +27% | +$166K | 0.01% | 574 |
|
|
2024
Q4 | $562K | Buy |
13,786
+89
| +0.6% | +$3.71K | 0.01% | 617 |
|
|
2024
Q3 | $534K | Buy |
13,697
+2,471
| +22% | +$98.4K | 0.01% | 663 |
|
|
2024
Q2 | $491K | Buy |
11,226
+2,618
| +30% | +$127K | 0.01% | 621 |
|
|
2024
Q1 | $411K | Sell |
8,608
-517
| -6% | -$23.2K | 0.01% | 673 |
|
|
2023
Q4 | $431K | Buy |
9,125
+1,776
| +24% | +$73.8K | 0.01% | 643 |
|
|
2023
Q3 | $350K | Buy |
7,349
+2,198
| +43% | +$120K | ﹤0.01% | 701 |
|
|
2023
Q2 | $300K | Sell |
5,151
-131
| -2% | -$7.86K | ﹤0.01% | 730 |
|
|
2023
Q1 | $378K | Sell |
5,282
-1,290
| -20% | -$102K | ﹤0.01% | 672 |
|
|
2022
Q4 | $463K | Buy |
6,572
+473
| +8% | +$33.3K | 0.01% | 629 |
|
|
2022
Q3 | $370K | Sell |
6,099
-36
| -0.6% | -$2.42K | ﹤0.01% | 654 |
|
|
2022
Q2 | $386K | Buy |
6,135
+88
| +1% | +$5.74K | ﹤0.01% | 649 |
|
|
2022
Q1 | $384K | Buy |
6,047
+526
| +10% | +$35.2K | ﹤0.01% | 691 |
|
|
2021
Q4 | $398K | Buy |
5,521
+159
| +3% | +$12.1K | ﹤0.01% | 697 |
|
|
2021
Q3 | $380K | Buy |
5,362
+248
| +5% | +$19.6K | ﹤0.01% | 674 |
|
|
2021
Q2 | $412K | Buy |
5,114
+49
| +1% | +$3.94K | ﹤0.01% | 656 |
|
|
2021
Q1 | $387K | Sell |
5,065
-958
| -16% | -$69.7K | ﹤0.01% | 607 |
|
|
2020
Q4 | $457K | Buy |
6,023
+35
| +0.6% | +$2.28K | 0.01% | 562 |
|
|
2020
Q3 | $293K | Sell |
5,988
-21
| -0.3% | -$1.19K | ﹤0.01% | 606 |
|
|
2020
Q2 | $316K | Sell |
6,009
-618
| -9% | -$29.3K | ﹤0.01% | 570 |
|
|
2020
Q1 | $231K | Buy |
6,627
+999
| +18% | +$58.4K | ﹤0.01% | 734 |
|
|
2019
Q4 | $500K | Buy |
5,628
+323
| +6% | +$28.2K | 0.01% | 462 |
|
|
2019
Q3 | $453K | Buy |
5,305
+5,175
| +3,981% | +$461K | 0.01% | 483 |
|
|
2019
Q2 | $14K | Hold |
130
| – | – | ﹤0.01% | 1072 |
|
|
2019
Q1 | $14K | Hold |
130
| – | – | ﹤0.01% | 1064 |
|
|
2018
Q4 | $11K | Sell |
130
-1,250
| -91% | -$113K | ﹤0.01% | 1068 |
|
|
2018
Q3 | $140K | Hold |
1,380
| – | – | ﹤0.01% | 651 |
|
|
2018
Q2 | $112K | Buy |
1,380
+1,250
| +962% | +$99.3K | ﹤0.01% | 668 |
|
|
2018
Q1 | $10K | Buy |
+130
| New | +$9.73K | ﹤0.01% | 1042 |
|
|
2017
Q2 | – | Sell |
-130
| Closed | -$8K | – | 993 |
|
|
2017
Q1 | $8K | Hold |
130
| – | – | ﹤0.01% | 983 |
|
|
2016
Q4 | $7K | Hold |
130
| – | – | ﹤0.01% | 957 |
|
|
2016
Q3 | $6K | Sell |
130
-25
| -16% | -$1.06K | ﹤0.01% | 933 |
|
|
2016
Q2 | $5K | Buy |
+155
| New | +$4.84K | ﹤0.01% | 911 |
|
Other funds holding NGVT
SBH
RA
SCM
Synovus Financial's NGVT Position: Q3 2025 in Review
Synovus Financial increased its Ingevity (NGVT) stake by 16% in Q3 2025, buying an estimated $181K and bringing the position to 24,961 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #452.
Synovus Financial first reported a position in NGVT in Q2 2016 and has held it in 35 quarters since. 298 funds tracked by Wall St. Rank hold NGVT as of Q3 2025.
- Synovus Financial held 24,961 shares of Ingevity worth $1.38M as of Q3 2025.
- Synovus Financial bought 3,472 Ingevity shares in Q3 2025, an estimated $181K.
- Ingevity made up 0.02% of Synovus Financial's portfolio in Q3 2025, its #452 holding.
- Synovus Financial first reported a position in Ingevity in Q2 2016 and has held it in 35 quarters since.
- 298 funds tracked by Wall St. Rank held Ingevity as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.